Search results for: 'application delivery'
- Related search terms
- application testing
- application protection
- application enablement platform
- application enablement platform iot
- Application of Data Mining and Big Data Analytics in the Construction Industry: Trends and Future outlook
-
21 Dec 2022  |  Global  |  Technology Research
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Jul 2024  |  Global  |  Strategic Forecasting
Top 10 Strategic Imperatives in the Healthcare IT Market, 2024
The Top Transformations Impacting Future Growth Potential
Current trends and challenges create constant change in the healthcare IT sector, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive view of industry context, drivers, restraints, and possibilities that lead to transformation. This a...
$2,450.00
Special Price $1,837.50 save 25 %
-
16 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Digital Pathology, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...
$4,950.00
Special Price $4,207.50 save 15 %
-
31 Jan 2024  |  North America  |  Market Research
Digital Health Regulations in North America and Europe: Growth Opportunities 2023
Innovative Business Models and Technologies are Leading to the Introduction of Disruptive Regulations
This report examines the regulations surrounding digital health in North America and Europe. It provides a general analysis of key national and regional regulatory updates that will impact digital health players and influence market dynamics. The regulatory documents considered are those governing the healthcare sector and applicable to digital hea...
$2,450.00
Special Price $1,837.50 save 25 %
-
12 Dec 2024  |  Global  |  Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...
$2,450.00
Special Price $2,082.50 save 15 %
-
27 Jan 2020  |  Global  |  Market Research
Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022
Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth
The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Oct 2024  |  Global  |  Market Research
Image-guided Therapy Market, Global, 2024-2029
Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In additi...
$4,950.00
Special Price $4,207.50 save 15 %
-
07 Nov 2017  |  North America  |  Market Research
Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021
Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success
The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...
$1,500.00
Special Price $1,125.00 save 25 %
-
13 Jan 2017  |  North America  |  Market Research
Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future
Consolidated Stability Storage is Leading to CROs Evolving into Development Partners and Driving the Stability Testing Outsourcing Market
This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosio...
$1,500.00
Special Price $1,125.00 save 25 %
-
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00
Special Price $3,712.50 save 25 %